MiniMed Group, Inc. Common Stock (MMED) is a publicly traded the market company. As of November 13, 2026, MMED trades at $17.75 with a market cap of $5.13B and a P/E ratio of -15.08. MMED moved -0.71% today. Year to date, MMED is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $10.65 to $24.43. Analyst consensus is strong buy with an average price target of $26.15. Rallies surfaces MMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for MMED shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $17.75 |
| Market Cap | $5.13B |
| P/E Ratio | -15.08 |
| EPS | $-1.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.43 |
| 52-Week Low | $10.65 |
| Volume | 10.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.10B |
| Net Income | $-317.00M |
| Gross Margin | 54.16% |
14 analysts cover MMED: 0 strong buy, 12 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.15.